Gender and the Future of Global Health

Total Page:16

File Type:pdf, Size:1020Kb

Gender and the Future of Global Health June 25, 2013– August 24, 2018 Contents The following blog posts were originally published on The Lancet Global Health Blog, which closed on December 31, 2018. 2018 42 Pandemic response: fear is inevitable, panic is optional C Simms 1 Ensuring quality care in Pakistan M H Zaman 44 Management of tuberculosis in pregnancy: 100 years later and we are still getting it wrong 3 Beginning the process: shaping global health in a multipolar world B-T Nyang’wa for the next 25 years R Seifman 46 Bridging the gap between global policy and local practice of respectful maternity care 5 After Argentina, other Latin American and Caribbean countries I de Vries and J Browne should not be afraid to debate abortion legalisation M Elder 48 Highlights from the second MSF Paediatric Days, Dakar, December 2017 7 Fixed-dose combination therapy for cardiovascular disease: S Nejat, with L Hiffler, D M Garcia, and A Kadir what can we learn from HIV? H Bygrave 51 Public-private partnership integrated health-care delivery: experience and lessons from Nepal 9 Ensuring prioritisation of gender and sexual minority health as R Schwarz and P Nepal part of our demands for UHC and LGBT+ rights A Raj and D Smith 55 Process matters when it comes to implementing the SDGs M Najafizada 11 Neglected tropical diseases and disability—what is the link? H Kuper 57 Global surgery and anaesthesia—expanding human capability S Juran 13 Biocitizenship and forced removals C Simms 59 Recommitting to children in the 2018 global AIDS agenda C Lyons 15 The new look of MDR and XDR-TB treatment: the times they are 61 Embracing global standards for community health care on Nepal’s a-changing H Huerga, U Khan, and K J Seung path towards universal health coverage A Thapa, P Chaudhary, and R Schwarz 17 India’s Pfizer litigation: balancing patentability and access to 63 Lessons from interactions between public health and the food and medicines? S Rajam and M Poddar drinks industry M Mwatsama and E Di Ruggiero 19 Mind the gap—closing the gaps in malaria research and 65 Visualizing an alternative biomedical R&D system development C Hogg J Reeder and J Whiting 67 The challenges faced by scientific journals in developing countries 20 Russia’s poor health does not need medicine, it needs evidence S R Mishra and D Neupane D Sarkisyan 22 Demanding a roadmap for non-communicable disease action: 2017 beyond “best buys” S G Ruchman, P Groden, D Newman, and N Sikka 69 Risks and opportunities as funding for polio disappears with the 24 1968: a revolutionary year, also for reproduction disease Nordic Ministers for Development L Kerr and L Stennett 26 Minamata Convention in Mozambique: are we searching under 71 Facing NTDs requires both WASH and health perspectives the wrong lamp post? L Qu F Brugger 73 The precarity of being indigenous: the case of Canada 28 To vaccinate more girls, involve the teachers C Simms B Atuhaire 75 Time to consider police brutality as a global health problem? 30 Urgent need for South Asian collaboration against A Milner and G Russo undifferentiated febrile illness 77 Women Leaders in Global Health: perspectives from emerging A Karkey leaders 32 Remote international medical teaching in North Korea T Jayaraman T Kim, T Kim, and J Zuckerman 79 A model for integrated action: IAEA, UNICEF and WHO collaborate 34 Diagnosis and treatment aren’t always enough: malaria must die to tackle the double burden of malnutrition É Gemme C Loechl 36 Men’s health: the case for global action 81 Innovative point-of-care diagnostic testing solutions emerge as a P Baker response to AMR 38 “Know your epidemic”: driving down HIV in London and beyond L Qu K Gedela 84 The one-way mirror of global health training 40 The need for a geopolitical shift in global health S Mehanni R Seifman and O Pannenborg 86 ‘Super Special Moms’: Grassroots, social media support group aids the response to congenital Zika syndrome K Lovero and C A Cardoso June 25, 2013– August 24, 2018 Contents (continued) 88 Cervical cancer deaths: a blind spot in global women’s health 135 Why efficiency savings shouldn’t be a last resort: lessons from C Fotheringham Uganda 90 What evidence is up against T Ngwaru J Bunting 137 Oxygen access in developing countries: a public health challenge 92 Melioidosis in south Asia: underground, underdiagnosed, and B Olayo dangerous 139 The Global Fund: where next? B Basnyat R Seifman 94 Can blockchain disrupt health education, licensing, and 141 In Yemen and other conflict zones, hospitals remain a target credentialling? C Monaghan A Peters 143 The epidemic of motorcycle road traffic injuries in the northeast of 97 Rehabilitation: a growing necessity in sub-Saharan Africa Brazil W Rule G Andreuccetti 99 Gender data: moving beyond sex-disaggregated analyses 145 Resisting resistance: how the G20 can foster political will to tackle A Raj antimicrobial resistance and turn the tide on tuberculosis 101 Surveillance for chronic kidney disease in agricultural communities M Imison and L Stennett in central America 147 2 years on: when democracy and tectonics collide P Ordunez and W Hoy D Maru and S R Mishra 103 Getting serious about financing the end of epidemics 149 Explaining Trumpcare: the appalling appeal C Collins C Simms 105 Critical reflections on meaningful youth contributions to global 151 Zika virus and the need for pharmaceutical preparedness health A Karan and T Pogge S W Sum Li 153 Safe global surgery needs effective non-technical skills 108 Evaluation in innovation—death threats and the importance of S Yi and Y Lin independence 155 To survive, health care needs small data to become adaptive R Marr D Maru and S Upreti 110 WHO has added snakebite to the NTD list: these things need to 157 Patient-centred R&D: where is the culture of inquiry and happen next innovation in LMICs? B Waldmann K R Pandey 112 Argentina must follow Germany’s lead on health at G20 159 World Malaria Day 2017—striving for malaria elimination is M Elder admirable but mind the (patient) gaps! 114 Do cash transfers help older people to access health services? B Rao F Galvani 161 The top five investments we should be making to tackle NTDs 116 Taking health in all policies seriously: health impact assessments, R Anderson and A Bettis WHO leadership, and international law 163 Refugee and migrant populations and the International Health E Friedman and G L Burci Regulations 118 Microbes as munitions: the neglected public health consequences R Seifman of war 165 Innovations in closing the global treatment gap for depression D Flecknoe C Lund 120 To the newly elected local leadership of Nepal: Invest in the 167 Students unite for open innovation and global access to expansion of emergency obstetric services, even where most tuberculosis drug sutezolid women deliver at home C Stone and M Basey S Maru 169 Accelerating progress to meet the goal of immunisation for all 122 Cyber threat, protection and resilience in humanitarian relief and K Mathieson response 171 Making the Coalition for Epidemic Preparedness Innovations E Perakslis (CEPI) more effective 124 The World Bank in Kagame’s Rwanda R Seifman C Simms 173 Setting the stage for improving childhood cancer outcomes: 126 Most access-to-medicine initiatives are poorly evaluated; the Sickkids-Caribbean Initiative here’s one effort to change that S Gupta and T Gibson D J Olson 175 Gender and the future of global health 128 Deteriorating mental health in a Greek refugee camp A Liu and K Thompson L MacFarlane 177 Is a global shift developing to reduce penalties for violence against 130 What lies ahead: the role of entrepreneurship in India’s rising women? public health sector J Wagman, J Silverman, and A Raj C Maru 179 Dr Mustapha Kaloko’s Opening Statement at the International 133 Safer prescriptions for the elderly: challenges and solutions from Conference on Global Surgery 2017 India M Kaloko and K H Yangni-Angate N Kshirsagar June 25, 2013– August 24, 2018 Contents (continued) 181 Rebuilding health post-conflict: how and where should we start? 223 Women’s bodily integrity: linking criminalisation of abortion and S Saleh and M Menassa criminalisation of HIV 183 Cancer organisations must step up on tobacco tax to make S Fried progress on cancer prevention 225 Water, sanitation, and hygiene must be the first lines of defence S Cowal and O Santamaria de Fernández against antimicrobial resistance 185 Global surgery in Latin America Y Velleman N Alonso and V Moutinho 227 How we can hold leaders accountable for the health of women, 186 Global health and Mr Trump’s “new world order” children, and adolescents everywhere C Simms C Barroso 188 Expanding access to medicines and technologies by expanding the 229 Fiscal space analysis for health: friend or foe? dialogue A Gheorghe D C Kaslow and C Friderichs 231 We won’t achieve sustainable development goals for NCDs or 190 Treating undernutrition in Borno State, Nigeria: adapting strategy other targets without tobacco taxes in emergencies J L Castro K Hanson 234 Young midwife leaders speak: a declaration of commitment and global call for action 2016 Young Midwifery Leaders 236 Health and climate: the road of opportunity 192 The digital health revolution: what does it mean for emerging N Watts and H Montgomery markets? M Mrazek and X Mou 238 The Global Fund replenishment 2016: a chance to tip the balance S O’Mallie 194 Doctors worldwide speak up for healthier energy choices V Gordeljevic 240 Rethinking undergraduate global health education: the Bellagio Global Health Education Initiative 196 Tackling neglected tropical diseases through human
Recommended publications
  • Eb138/2016/Rec/2
    EB122/2008 EB138/2016/REC/2 /REC/ 2 WORLD HEALTH ORGANIZATION EXECUTIVE EXECUTIVE EXECUTIVE BOARD 138TH SESSION BOARD, 122 BOARD, GENEVA, 25–30 JANUARY 2016 ND SESSION: SUMMARY RECORDSSESSION: SUMMARY SUMMARY RECORDS LIST OF PARTICIPANTS GENEVA 2016 ABBREVIATIONS Abbreviations used in WHO documentation include the following: ACHR – Advisory Committee on Health OIE – Office International des Research Epizooties ASEAN – Association of Southeast Asian PAHO – Pan American Health Nations Organization CEB – United Nations System Chief UNAIDS – Joint United Nations Programme Executives Board for on HIV/AIDS Coordination UNCTAD – United Nations Conference on CIOMS – Council for International Trade and Development Organizations of Medical UNODC – United Nations Office on Drugs Sciences and Crime FAO – Food and Agriculture UNDP – United Nations Development Organization of the United Programme Nations UNEP – United Nations Environment IAEA – International Atomic Energy Programme Agency UNESCO – United Nations Educational, IARC – International Agency for Scientific and Cultural Research on Cancer Organization ICAO – International Civil Aviation UNFPA – United Nations Population Fund Organization UNHCR – Office of the United Nations IFAD – International Fund for High Commissioner for Refugees Agricultural Development UNICEF – United Nations Children’s Fund ILO – International Labour UNIDO – United Nations Industrial Organization (Office) Development Organization IMF – International Monetary Fund UNRWA – United Nations Relief and Works IMO – International
    [Show full text]
  • The GEMMA Fund Fifth Annual Report: 2013-2014
    The GEMMA Fund Fifth Annual Report: 2013-2014 AP Photo/Matilde Campodonico *Photo: A pro-abortion activist participating in the September 25th, 2012 demonstration in favor of legal- ization of abortion in Montevideo, Uruguay. This action was a protest of the decriminalization law which passed in October 2012, because the law (currently in place) is so restrictive. More than a dozen women were part of the nude demonstration, painted orange with owers, while others were dressed in orange. Demonstrators held signs saying "Aborto Legal" (Legal Abortion). Marta Agunin, who directs Women and Health [MYSU], a non-governmental organization in Uruguay, complained “This is not the law for which we fought for more than 25 years” Developed and designed by Jenny Holl and Gelsey Hughes, March 2015. *http://www.timesunion.com/news/article/Uruguay-poised-to-legalize-abortion-3893945.php#photo-3506159 Mission The GEMMA Fund supports Emory University graduate students’ research and their collaborations with public health organizations to contribute to the prevention of maternal deaths from abortion. Background The World Health Organization (WHO) reports that 21 million women worldwide receive unsafe abortions every year, resulting in 47,000 maternal deaths annually (13% of all maternal deaths). Nearly all (98%) of unsafe abortions take place in developing countries. The WHO estimates that if all women were able to attain the same quality of abortion services available in the United States, fewer than 100 women would die from abortions each year, but for
    [Show full text]
  • Data As of 29 November 2018, Compared to the Same Point in 2017
    November 2018 Dear polio eradication supporter, As we near the year’s end, the three remaining endemic countries continue their intense emergency efforts to stop polio. At the heart of these campaigns are the millions of health workers who have gone above and beyond the call of duty to help reach every last child with the polio vaccine. From the vaccinators who helped eliminate polio in India in 2011 to those running immunization campaigns in Afghanistan last month, the programme is grateful for the continuing dedication to ending the disease for good. The promise of a new year will be a good time to renew our efforts and use innovative approaches, with health workers on the ground leading the way. • Polio remains a public health emergency IN THIS ISSUE • Commission proposes updated process for certifying polio eradication • Polio outbreak stopped in Syria 2018 27 19 8 0 2017 22 11 5 0 Data as of 29 November 2018, compared to the same point in 2017. Polio remains a public health emergency So close to ending polio for good, it is more important than ever to maintain momentum against the virus. WHO’s emergency committee affirmed this need for urgency last week by announcing that the risk of international spread of poliovirus remains a Public Health Emergency of International Concern (PHEIC). The committee’s experts cited complacency as the biggest risk, and added continuing challenges in Afghanistan and Pakistan and the spread of VDPVs as key factors in their decision. They warned that without strong efforts, polio could return to paralyze 200 000-300 000 children every year.
    [Show full text]
  • Philippines: the Protection Offered to Female Victims of Sexual Abuse Research Directorate, Immigration and Refugee Board of Canada, Ottawa
    Home > Research > Responses to Information Requests RESPONSES TO INFORMATION REQUESTS (RIRs) New Search | About RIR's | Help 13 March 2008 PHL102719.E Philippines: The protection offered to female victims of sexual abuse Research Directorate, Immigration and Refugee Board of Canada, Ottawa Freedom House reports that "[r]ape, domestic violence, [and] sexual harassment on the job ... continue to be major problems despite efforts in government and civil society to protect women from violence and abuse" (2007). Similarly, Country Reports on Human Rights Practices for 2006 states that violence against women "remained a serious problem" (US 6 Mar. 2007, Sec. 5). According to the Philippine Star, the Department of Social Welfare and Development (DSWD) reported 22,724 victims of sexual abuse from 2000 to 2005 (27 Sept. 2007). The DSWD, which provides programs and services for specific groups including women (Philippines n.d.a), reports on its website that it provided assistance to 237 female victims of rape, 91 female victims of incest and 5 female victims of "acts of lasciviousness" in 2006 (ibid. n.d.b). According to the National Commission on the Role of Filipino Women (NCRFW), the number of cases of violence against women increased from 1,100 in 1996 to 6,505 in 2005, and police records for 2005 indicate that 17.2 percent of cases reported to the police were rape cases (Philippines Mar. 2006). The Anti-Rape Law of 1997, which amends the definitions of the crime of rape in the Revised Penal Code, also defines marital rape as a crime unless the wife forgives the offender (i.e., her husband) (ibid.
    [Show full text]
  • 3.Philippines
    LAWS AND POLICIES AFFECTING THEIR REPRODUCTIVE LIVES PAGE 123 3. Philippines Statistics GENERAL Population ■ Total population (millions): 83.1.1 ■ Population by sex (thousands): 40,418.2 (female) and 40,990.0 (male).2 ■ Percentage of population aged 0–14: 36.5.3 ■ Percentage of population aged 15–24: 20.3.4 ■ Percentage of population in rural areas: 39.5 Economy ■ Annual percentage growth of gross domestic product (GDP): 3.5.6 ■ Gross national income per capita: USD 1,080.7 ■ Government expenditure on health: 1.5% of GDP.8 ■ Government expenditure on education: 2.9% of GDP.9 ■ Percentage of population below the poverty line: 37.10 WOMEN’S STATUS ■ Life expectancy: 73.1 (female) and 68.8 (male).11 ■ Average age at marriage: 23.8 (female) and 26.3 (male).12 ■ Labor force participation: 54.8 (female) and 84.3 (male).13 ■ Percentage of employed women in agricultural labor force: Information unavailable. ■ Percentage of women among administrative and managerial workers: 58.14 ■ Literacy rate among population aged 15 and older: 96% (female) and 96% (male).15 ■ Percentage of female-headed households: 11.16 ■ Percentage of seats held by women in national government: 18.17 ■ Percentage of parliamentary seats occupied by women: 15.18 CONTRACEPTION ■ Total fertility rate: 3.03.19 ■ Contraceptive prevalence rate among married women aged 15–49: 49% (any method) and 33% (modern method).20 ■ Prevalence of sterilization among couples: 10.4% (total); 10.3% (female); 0.1% (male).21 ■ Sterilization as a percentage of overall contraceptive prevalence: 22.4.22 MATERNAL HEALTH ■ Lifetime risk of maternal death: 1 in 90 women.23 ■ Maternal mortality ratio per 100,000 live births: 200.24 ■ Percentage of pregnant women with anemia: 50.25 ■ Percentage of births monitored by trained attendants: 60.26 PAGE 124 WOMEN OF THE WORLD: ABORTION ■ Total number of abortions per year: Information unavailable.
    [Show full text]
  • Global Immunization News (GIN) February 2016
    Global Immunization News (GIN) February 2016 In this issue News You can click on the article you are interest- Post-introductory evaluation of the pneumococcal conjugated and ed in and access it di- inactivated polio myelitis vaccines in Bangladesh rectly! Wijesinghe Pushpa Ranjan and Nihal Abeysinghe, World Health Organization, Regional Office for South- East Asia; Stephen Chacko and Jayantha Liyanage, WHO Country Office, Bangladesh Bangladesh, a pioneer in new vaccine introductions in the WHO’s News South-East Asia region, simultaneously introduced the Pneumococcal Preparations acceler- 2 Conjugated Vaccine (PCV) and Inactivated Poliomyelitis Vaccine ate towards the OPV switch (IPV) in March 2015. At the request of the Ministry of Health and Securing a Polio-Free 2 Family Welfare, WHO’s South East Asia Regional Office (SEARO) World: Video Series and the WHO Country Office in Bangladesh supported a post intro- ductory evaluation (PIE) in November 2015. Past meetings / workshops Meeting of the Re- 3 The PIE assessed; (a) strengths and weaknesses of immunization ser- gional Measles and vice delivery at all health care delivery levels, current vaccine distri- Rubella Laboratory bution mechanisms and cold chain management, (b) injection safety Network and immunization waste management practices for sharps, (c) the Utilization of Mobile 4 Technology for Rapid capacity for management of Adverse Events Following Immunization, Convenience Moni- and (d) described lessons learned from the process of introducing toring (RCM) during two new vaccines simultaneously. Measles-Rubella Cam- paign 2016 in Nepal Eight PIE teams consisting of one international evaluator and two Dr Selina Ahmed (WHO Bangla- desh) interviews a vaccinator in national evaluators in a team visited 17 districts/City Corporations, Calendar 5 Purbadhala Upazilla.
    [Show full text]
  • Establishment of a Subcommittee for Polio Eradication and Outbreaks Introduction 1
    Regional Committee for the Eastern Mediterranean EM/RC67/17 Sixty-seventh session October 2020 Provisional agenda item 8 Establishment of a Subcommittee for Polio Eradication and Outbreaks Introduction 1. As part of efforts to secure a polio-free world, it is proposed to establish a subcommittee of health ministers from Member States of the Eastern Mediterranean Region of the World Health Organization (WHO) to advocate for and champion polio eradication. The subcommittee will serve to support the remaining wild poliovirus-endemic and polio outbreak-affected countries in the Region in their intensified polio eradication efforts and help to facilitate polio transition. 2. Rule 16, under section VII of the current Rules of Procedure of the Regional Committee for the Eastern Mediterranean, provides the authority to establish such subcommittees as the Committee deems necessary to study and report on any item on its agenda. Background 3. The goal of the Global Polio Eradication Initiative, launched in 1988, is to ensure that no child will ever again be paralysed by any poliovirus. Since 1988, the incidence of wild poliovirus has declined by 99.9% globally, from more than 350 000 cases every year in more than 125 endemic countries, to 165 cases in two countries in 2019 – Pakistan and Afghanistan. On 25 August 2020, the WHO African Region was certified as free of wild poliovirus, following previous declarations in the regions of the Americas (1994), the Western Pacific (2000), Europe (2002) and South-East Asia (2014). 4. While the human resources and other assets of the regional polio eradication programme have made a substantial contribution to national responses to the COVID-19 pandemic, the programme has experienced setbacks due to a decline in surveillance for poliovirus and a four-month pause in polio vaccination activities.
    [Show full text]
  • Global Immunization News (GIN) October 2016
    Global Immunization News (GIN) October 2016 In this issue News You can click on the article you are interested in and ac- Where are we with the implementation of the Global Vaccine Action Plan (GVAP) at cess it directly! mid-term of the Decade of Vaccines? News Every year, the Decade of Vaccines Updated resources for moni- 2 secretariat (see details below) pre- toring home-based records Further, Faster, Fairer: Reach- 2 pares a report which summarizes ing every last child with im- the progress against each of the munization GVAP goals (coverage, disease elim- New work with countries to 3 ination, vaccine prices, NITAGs…). generate and use evidence on This report is the best source of vaccine delivery cost for information available for a clear planning and budgeting picture of the situation in all areas Launch of Stop Pneumonia 3 website, a great resource of work in the immunization world ahead of World Pneumonia (research, procurement, logistic, Day 2016 delivery, demand…). MSF rejects Pfizer PCV Dona- 4 tion offer This year, the GVAP Secretariat report 2016 is composed of several Past meetings / workshops 5-13 pieces: 1. The usual GVAP secretariat re- Resources 14 port (all goals and strategic goal indicators) Calendar 15 2. Six regional progress reports 3. Seven priority countries pro- Links 16 gress reports 4. The Score Cards for immuniza- tion summarizing the immuniza- tion coverage for all antigens and for all countries from 2000 to GVAP and National Immunization coverage scorecards estimates for 2015 2015 All those documents serve as the basis for the independent review conducted by the Strategic Ad- visory Group of Experts on immunization (SAGE).
    [Show full text]
  • Safety Data Sheet: Brilliant Green (C.I. 42040)
    Safety data sheet according to Regulation (EC) No. 1907/2006 (REACH), amended by 2015/830/EU Brilliant green (C.I. 42040) for microscopy article number: 0324 date of compilation: 2020-01-28 Version: 1.0 en SECTION 1: Identification of the substance/mixture and of the company/ undertaking 1.1 Product identifier Identification of the substance Brilliant green (C.I. 42040) Article number 0324 Registration number (REACH) It is not required to list the identified uses be- cause the substance is not subject to registration according to REACH (< 1 t/a) EC number 211-190-1 CAS number 633-03-4 1.2 Relevant identified uses of the substance or mixture and uses advised against Identified uses: laboratory chemical laboratory and analytical use 1.3 Details of the supplier of the safety data sheet Carl Roth GmbH + Co KG Schoemperlenstr. 3-5 D-76185 Karlsruhe Germany Telephone: +49 (0) 721 - 56 06 0 Telefax: +49 (0) 721 - 56 06 149 e-mail: [email protected] Website: www.carlroth.de Competent person responsible for the safety data : Department Health, Safety and Environment sheet: e-mail (competent person): [email protected] 1.4 Emergency telephone number Name Street Postal code/city Telephone Website National Poisons In- Dudley Rd B187QH Birmingham 844 892 0111 formation Service City Hospital Emergency information service +49/(0)89 19240 SECTION 2: Hazards identification 2.1 Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 (CLP) Classification acc. to GHS Section Hazard class Hazard class and cat- Hazard egory state- ment 3.1O acute toxicity (oral) (Acute Tox.
    [Show full text]
  • Vaccines and Global Health :: Ethics and Policy
    Vaccines and Global Health: The Week in Review 3 March 2018 Center for Vaccine Ethics & Policy (CVEP) This weekly digest targets news, events, announcements, articles and research in the vaccine and global health ethics and policy space and is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. Vaccines and Global Health: The Week in Review is also posted in pdf form and as a set of blog posts at https://centerforvaccineethicsandpolicy.net. This blog allows full-text searching of over 8,000 entries. Comments and suggestions should be directed to David R. Curry, MS Editor and Executive Director Center for Vaccine Ethics & Policy [email protected] Request an email version: Vaccines and Global Health: The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EST/U.S.). If you would like to receive the email version, please send your request to [email protected]. Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution. Contents [click on link below to move to associated content] A. Milestones :: Perspectives :: Featured Journal Content B. Emergencies C. WHO; CDC [U.S., Africa, China] D.
    [Show full text]
  • Laws on Violence Against Women in the Philippines
    EGM/GPLVAW/2008/EP.12 22 August 2008 ENGLISH only United Nations Nations Unies United Nations Office on Drugs and Crime United Nations Division for the Advancement of Women Expert Group Meeting on good practices in legislation on violence against women United Nations Office at Vienna, Austria 26 to 28 May 2008 Laws on Violence against Women in the Philippines Expert Paper prepared by: Rowena V. Guanzon* Professor, University of the Philippines College of Law Steering Committee Member, Asia Cause Lawyers Network * The views expressed in this paper are those of the author and do not necessarily represent those of the United Nations. 1 EGM/GPLVAW/2008/EP.12 22 August 2008 ENGLISH only Background: Since 1995, violence against women (VAW) has captured the attention of the government and legislators in the Philippines, propelled by the demand of a growing women’s human rights movement and the Convention on the Elimination of All Forms of Discrimination Against Women, its Optional Protocol1 as well as other international conventions. The Beijing Conference on Women in 1995 heightened the demand of women’s rights advocates for laws protecting women from violence. Progressive reforms in laws protecting women was brought about by several factors beginning with the democratization process that began in the 1986 People Power Revolution after the fall of the Marcos dictatorship, the 1987 Constitution2 that has specific provisions on the rights of women and fundamental equality before the law of men and women, the increasing number of women’s organizations in the provinces with links to Metro Manila based women’s rights organizations,3 and the participation of women legislations who are becoming increasingly aware of the need for gender equality and the elimination of VAW.
    [Show full text]
  • Vaccines: the Week in Review
    Vaccines and Global Health: The Week in Review 13 May 2017 Center for Vaccine Ethics & Policy (CVEP) This weekly digest targets news, events, announcements, articles and research in the vaccine and global health ethics and policy space and is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. Vaccines and Global Health: The Week in Review is also posted in pdf form and as a set of blog posts at https://centerforvaccineethicsandpolicy.net. This blog allows full-text searching of over 8,000 entries. Comments and suggestions should be directed to David R. Curry, MS Editor and Executive Director Center for Vaccine Ethics & Policy [email protected] Request an email version: Vaccines and Global Health: The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EST/U.S.). If you would like to receive the email version, please send your request to [email protected]. Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution. Contents [click on link below to move to associated content] A. Milestones :: Perspectives :: Featured Journal Content B. Emergencies: Polio; Zika; Ebola/EVD; MERS-Cov; Yellow Fever C.
    [Show full text]